Twelve-Month Results of a Single or Multiple Dexamethasone Intravitreal Implant for Macular Edema following Uncomplicated Phacoemulsification

Table 3

Intraocular pressure (mmHg) prior to treatment and at follow-up intervals.

	Baseline	Day 7	Mo. 1	Mo. 2	Mo. 4	Mo 6	Mo. 8	Mo. 12
1	17	14	14	14	14	14	13	14
2	11	16	13	13	13	13	13	13
3	14	17	16	13	—	—	—	—
4	13	21	21	20	18^t	14^t	—	—
5	14	16	12	12	14	13	13	16
6^*	14	16	14	16	16	18	18	16
7^*	14	16	20	17^t	18^t	15^t	16^t	16^t
8^*	15	19	19	18	16	15	20	16
9^*	15	17	16	17	17	16	16	14
10^*	15	16	17	16	16	17	17	17
Mean	14.2	16.8	16.2	15.6	15.8	15	15.8	16
Median	14	16	16	16	16	15	16	16
SD	1.5	1.9	3.0	2.5	1.8	1.7	2.6	1.4
Range	11–17	14–21	12–21	12–20	13–18	13–18	13–20	13–17
value^†		0.031	0.120	0.165	0.091	0.228	0.158	0.222
Delta^‡		2.6	2.0	1.4	1.6	0.8	1.6	1.8

Patients denoted with had a second implant at month 7.
Patients dropped out from the study.
^† value refers to Wilcoxon signed-rank test on the median values with respect to the baseline.
^‡Delta denotes the mean difference with the baseline.
^tPatients who were prescribed topical intraocular pressure lowering medication.
Mo.: month.